Brought to you by 
Durect and NeuroSystec collaborate on inner ear
18 Feb 2005
Executive Summary
Durect Corp. and NeuroSystec Corp. (researching the delivery of neurologically active drugs via ultraminiature implantable devices) agreed to develop and commercialize products for treating inner ear disorders, such as chronic tinnitus.
Deal Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Durect and NeuroSystec collaborate on inner ear
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice